Live feed08:45:00·20dPRReleasevia QuantisnowVivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq ListingByQuantisnow·Wall Street's wire, on your screen.VVOS· Vivos Therapeutics Inc.Health Care